ReviewDermatology and therapy2025

Brodalumab as a Second-Line Therapy in Psoriasis: Rapid Response and Unique Mechanism of Action After Biologic Failure.

Lawrence Green et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.